Iwaki achieved sales of 4.77 billion yen (up 4.2% YoY) for the fiscal year ending March 2026, with net profit of 484 million yen (up 8.2% YoY). The water treatment market for medical devices and semiconductors continues to perform well, and steady growth is anticipated in this fiscal year.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"6237","jir_company_name":"Iwaki Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-05-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/6237-20260514-04.pdf","jir_short_summary":"Iwaki achieved sales of 4.77 billion yen (up 4.2% YoY) for the fiscal year ending March 2026, with net profit of 484 million yen (up 8.2% YoY). The water treatment market for medical devices and semiconductors continues to perform well, and steady growth is anticipated in this fiscal year.","jir_summary":"### Financial Performance Overview\nIwaki achieved sales of 4.77 billion yen (up 4.2% YoY), operating income of 592 million yen (up 1.4%), and net income of 484 million yen (up 8.2%) for the fiscal year ending March 2026. The water treatment market for medical devices and semiconductors performed favorably, with the magnet pump as the main product leading the growth. Overseas markets also remain steady, with sales increasing mainly in the United States and China. Going forward, the company aims for steady growth based on solution proposals.\n\n### Future Outlook and Impact on Shareholders\nThe earnings forecast for the fiscal year ending March 2027 projects sales of 5.096 billion yen (up 6.8% YoY) and net income of 515 million yen (up 6.5%). Despite geopolitical uncertainties in the Middle East, the stable growth is expected to continue supported by the strong water treatment and medical device markets. An increase in dividends is also anticipated, emphasizing shareholder returns. The company will continue share buybacks and capital policy initiatives to enhance corporate value.","jir_financial_highlights":"Sales Revenue: 47,692 million yen (Up 4.2% YoY)\nNet Income Attributable to Owners of Parent: 4,835 million yen (Up 8.2% YoY)\nOperating Income: 5,924 million yen (Up 1.4% YoY)","jir_category":"","jir_hashtags":"#Iwaki, #FinancialResults, #JapaneseStocks","jir_key_figures":"Sales Revenue: 47,692 million yen (up 4.2% YoY)\nNet Income Attributable to Owners of Parent: 4,835 million yen (up 8.2% YoY)\nSales forecast for March 2027: 5.096 billion yen (up 6.8% YoY)","jir_meta_title":"\u3010Iwaki\u30112026 Fiscal Year Financial Results \uff5c Revenue of 4.77 billion yen (+4.2%) \uff5c May 2026","jir_meta_description":"Iwaki achieved sales of 4.77 billion yen (up 4.2% YoY) for the fiscal year ending March 2026. The medical and semiconductor water treatment businesses are strong, maintaining growth momentum.","jir_og_title":"\u3010Iwaki\u30112026 Fiscal Year Financial Results \uff5c Revenue of 4.77 billion yen (+4.2%) \uff5c May 2026","jir_og_description":"Iwaki achieved sales of 4.77 billion yen and net income of 484 million yen for the fiscal year ending March 2026. Continued steady growth and shareholder returns are planned.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Sales Revenue Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2024\\\",\\\"2025\\\",\\\"2026\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Sales Revenue (billion yen)\\\",\\\"data\\\": [4.576, 4.769, 4.77],\\\"borderColor\\\": \\\"#36A2EB\\\",\\\"fill\\\": false}]}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2024\\\",\\\"2025\\\",\\\"2026\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Operating Income (billion yen)\\\",\\\"data\\\": [0.584, 0.592, 0.592],\\\"borderColor\\\": \\\"#FF6384\\\",\\\"fill\\\": false}]}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Trend\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"2024\\\",\\\"2025\\\",\\\"2026\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"Net Income (billion yen)\\\",\\\"data\\\": [0.447, 0.484, 0.484],\\\"borderColor\\\": \\\"#4BC0C0\\\",\\\"fill\\\": false}]}\"}, {\"jir_chart_id\": \"segment_revenue_breakdown\", \"jir_chart_type\": \"pie\", \"jir_chart_title\": \"Segment-wise Revenue Composition\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"Medical Equipment\\\",\\\"Semiconductors & Displays\\\",\\\"Water Treatment\\\"],\\\"datasets\\\": [{\\\"data\\\": [18.8, 15.4, 11.4],\\\"backgroundColor\\\": [\\\"#FF6384\\\",\\\"#36A2EB\\\",\\\"#FFCE56\\\"]}]}\"}, {\"jir_chart_id\": \"guidance_comparison\", \"jir_chart_type\": \"bar\", \"jir_chart_title\": \"Forecast vs Actual for 2027\", \"jir_chart_json_data\": \"{\\\"labels\\\": [\\\"Sales Revenue\\\",\\\"Net Income\\\"],\\\"datasets\\\": [{\\\"label\\\": \\\"2026 Actuals\\\",\\\"data\\\": [4.77, 0.484],\\\"backgroundColor\\\": \\\"#36A2EB\\\"},{\\\"label\\\": \\\"2027 Forecast\\\",\\\"data\\\": [5.096, 0.515],\\\"backgroundColor\\\": \\\"#FF6384\\\"}]}\"}]","ir_related_company":17230,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-51674","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n